JoanneKurtzbergMD

Clinical Trials

• Blood and Marrow Transplant Clinical Research Network Start of enrollment: 2001 Sep 01

  Completed

  Not Applicable

• Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia Start of enrollment: 1999 Jan 01

  Completed

  Phase 2

• Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01

  Completed

  Phase 3

• Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01

  Terminated

  Phase 2, Phase 3

• Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) Start of enrollment: 2005 Sep 01

  Completed

  Phase 2

• Safety and Efficacy of Prochymal® for the Salvage of Treatment-Refractory Acute GVHD Patients Start of enrollment: 2005 Nov 18

  Completed

  Phase 2

• Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01

  Completed

  Phase 3

• Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis Start of enrollment: 2007 Jul 01

  Withdrawn

  Phase 1, Phase 2

• Adult Double Cord Blood Transplant Study Start of enrollment: 2007 Aug 01

  Completed

  Phase 2

• Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy Start of enrollment: 2008 Jan 01

  Completed

  Phase 1

• ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases Start of enrollment: 2008 Mar 01

  Terminated

  Phase 3

• Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies Start of enrollment: 2007 Aug 01

  Completed

  Phase 1, Phase 2

• Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells Start of enrollment: 2005 Oct 01

  Completed

  Phase 1

• Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases Start of enrollment: 2009 Oct 01

  Withdrawn

  Phase 1

• A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy Start of enrollment: 2010 Jun 01

  Completed

  Phase 2

• Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies Start of enrollment: 2010 Nov 01

  Completed

  Phase 1, Phase 2

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01

  Recruiting

  Roles: Contact, Principal Investigator

• Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders Start of enrollment: 2011 Apr 01

  Terminated

  Phase 1, Phase 2

• Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome Start of enrollment: 2011 Sep 01

  Terminated

  Phase 1

• Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation Start of enrollment: 2012 Mar 01

  Withdrawn

  Phase 2

• Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies Start of enrollment: 2012 Sep 01

  Completed

  Phase 1, Phase 2

• Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

  Available

• Single Patient Expanded Access Protocol: Metabolic Boost

  No longer available

• Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)

  No longer available

• Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD) Start of enrollment: 2014 Jun 01

  Completed

  Phase 1

• UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells Start of enrollment: 2014 Sep 01

  Recruiting

  Phase 1

• Cord Blood Infusion for Children With Autism Spectrum Disorder Start of enrollment: 2016 Sep 01

  Completed

  Phase 2

• Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke Start of enrollment: 2017 Mar 14

  Completed

  Phase 2

• hCT-MSCs for Children With Autism Spectrum Disorder (ASD) Start of enrollment: 2017 Jun 06

  Completed

  Phase 1

• Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries

  Available

• A Study of UCB and MSCs in Children With CP: ACCeNT-CP Start of enrollment: 2018 Apr 10

  Completed

  Phase 1, Phase 2

• Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE Start of enrollment: 2018 Dec 27

  Completed

  Phase 1

• hCT-MSC in Children With Autism Spectrum Disorder Start of enrollment: 2020 Oct 12

  Completed

  Phase 2

• Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder Start of enrollment: 2021 Feb 24

  Completed

  Phase 1

• hCT-MSCs for COVID19 ARDS Start of enrollment: 2020 Jun 18

  Terminated

  Phase 1, Phase 2

• hCT-MSC Infusion in Adults With Autism Spectrum Disorder Start of enrollment: 2022 Jan 24

  Active, not recruiting

  Phase 1

• Infusions of Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome Start of enrollment: 2021 Mar 12

  Withdrawn

  Phase 1

• Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) Start of enrollment: 2022 Apr 19

  Recruiting

  Phase 2

  Roles: Principal Investigator

• Join now to see all